Evidence map›Paper›PMID 17698623›Full record

ArticleAntimicrobial agents and chemotherapy2007

The antifungal polyketide ambruticin targets the HOG pathway.

Leandro Vetcher, Hugo G Menzella, Toshiaki Kudo, Takayuki Motoyama, Leonard Katz

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. The Corey-Seebach Reagent in the 21st Century: A Review.Molecules (Basel, Switzerland) · 2023
    Review
  5. Article
  6. Current Landscape of Coccidioidomycosis.Journal of fungi (Basel, Switzerland) · 2022
    Review
  7. Article
  8. The Future of Antifungal Drug Therapy: Novel Compounds and Targets.Antimicrobial agents and chemotherapy · 2021
    Review
  9. Article
  10. Uncertainty surrounding the mechanism and safety of the post-harvest fungicide fludioxonil.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2019
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. mSphere
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Leandro VetcherKosan Biosciences Inc, Hayward, CA 94545, USA.
Hugo G Menzella
Toshiaki Kudo
Takayuki Motoyama
Leonard Katz

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The polyketide ambruticin is an attractive candidate for drug development as an antifungal agent, but its mechanism of action has not yet been elucidated. Here we present evidence that ambruticin exerts its effect by targeting HOG, the osmotic stress control pathway, through Hik1, a group III histidine kinase.

Indexed as

Antifungal AgentsBlotting, WesternFungiGlycerolMicrobial Sensitivity TestsMitogen-Activated Protein KinasesOsmolar ConcentrationPhosphorylationPyransSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSignal TransductionYeastsambruticinAntifungal AgentsGlycerolHOG1 protein, S cerevisiaeMitogen-Activated Protein KinasesPyransSaccharomyces cerevisiae Proteins

Identifiers

PMID17698623
PMCPMC2043265

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.